The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.
about
New viruses for cancer therapy: meeting clinical needsSignaling Pathways in Thyroid Cancer and Their Therapeutic ImplicationsSodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancerB-RafV600E inhibits sodium iodide symporter expression via regulation of DNA methyltransferase 1Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.New therapies for dedifferentiated papillary thyroid cancerModulation of sodium iodide symporter in thyroid cancerAssociation between sodium iodide symporter and differentiated Thyroid cancer: a meta-analysis of 9 studies.The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells.The Na+/I- symporter (NIS): mechanism and medical impact.Utility of single photon emission tomography/computed tomography in characterizing an additional focus of iodine uptake in post-treatment whole body iodine scan.Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine.Tumor suppressor protein p53 exerts negative transcriptional regulation on human sodium iodide symporter gene expression in breast cancer.Synthesis of 18F-Tetrafluoroborate via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model.Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancers.FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-β1/Smad signaling pathway.Physiological sodium concentrations enhance the iodide affinity of the Na+/I- symporter.Histone post-translational modifications induced by histone deacetylase inhibition in transcriptional control units of NIS gene.A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.The role of micronutrients in the response to ambient air pollutants: Potential mechanisms and suggestions for research design.The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumorsCooperation of histone deacetylase inhibitors SAHA and valproic acid in promoting sodium/iodide symporter expression and function in rat Leydig testicular carcinoma cells.Vitamin A, endocrine tissues and hormones: interplay and interactions.Small activating RNA upregulates NIS expression: promising potential for hepatocellular carcinoma endoradiotherapy.Percutaneous microwave ablation of thyroid nodules: effects on thyroid function and antibodies.Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer.The Effect of Diagnostic Absorbed Doses from 131I on Human Thyrocytes in Vitro.Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention.Radiotheranostics in Cancer Diagnosis and Management.Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study.Cancer: Novel target to enhance radioiodine uptake in thyroid cancer.Therapeutic effects of adenovirus-mediated CD and NIS expression combined with Na131I/5-FC on human thyroid cancer.Novel targeted therapies and immunotherapy for advanced thyroid cancers.The correlation between breast cancer and urinary iodine excretion levels.Sodium iodide symporter in the fight against thyroid cancer.LARP7 in papillary thyroid carcinoma induces NIS expression through suppression of the SHH signaling pathway.Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression.
P2860
Q24567699-1ED6936D-C25B-4181-BAA9-168EA576EC94Q26764899-901FC468-F126-4798-82EC-5F49D66C7CAAQ33603806-6CE40FDB-4603-44F9-BD10-FF445AC6D6DEQ34669305-CBD132BC-ED9E-4B74-8136-B15C5271C9E5Q34698684-B7F3984F-E5F0-4A69-8CEB-423C96935C6FQ35381593-6950D9FE-B4D1-4002-BFA0-B6B451E6D47DQ35690173-018501A7-4E23-41AF-9D0D-E5EDC584A30FQ36411684-C97F438B-30BE-42EE-9B72-45710F2A2FB7Q37211959-4D30DB9D-58F7-4AE8-A967-0BE027BBF000Q37494004-DE73525A-7B3C-486D-8ED0-AF37DA96676BQ37718616-644ACD5F-119E-4064-96FB-9506D1D471C0Q38675367-6C373D4C-F69D-4B86-9CA3-6BC8EADE3118Q38772797-23406BC8-9985-4F89-885E-1929C7F542B9Q38776310-49BFE789-E3FE-400D-8521-F1BD584025B7Q38835322-4E480A99-981C-4B00-A1CD-7042CBB003EDQ38844406-8C9A9DCE-99C5-4351-990A-C06249488335Q38989161-A097DF95-1D12-45AD-B7D6-5A34558EF151Q38993423-598E2E5E-D63B-4756-AA0D-58EF965E3005Q39002421-49D8624E-F81A-4253-B01B-F1E29BBFA018Q39113282-F30B2E65-E598-4B4E-9FC7-D5266CBE22F7Q39133291-52F52EF3-43FA-49BC-A6F5-2D57E919BC9DQ39151345-047CCFFE-661B-41C4-AA6D-0527801572FBQ39157582-79F8026A-81CB-4D0F-8238-E2B6C3DEB2C0Q39442677-4127E77F-855C-4D3A-9A7C-276D242197BAQ40485794-45867CA8-1200-45BA-95A4-ED332637BD77Q40998908-CB75AF73-8250-408D-8C5C-D422984B0BD5Q41677197-63676009-3225-4A57-A35E-2F3933C3846AQ42407359-6149C807-35F0-48A4-AE58-A0A5A2B3DBCAQ42551493-C0353B6A-AAF4-4ACE-A99C-F64A42BA0F59Q47719762-12119B7D-BC75-4355-90C3-898F383D1B1AQ48296048-F51A5081-EB9C-4187-A43B-FDF46F5DBEC0Q48454756-F2613B62-8694-4843-8ECA-DE1D187924C2Q49207200-0AB2CDB4-C342-405D-BE4D-45C594E55D3AQ49887965-4802EED3-2F87-476E-85B8-8C19CCF17F80Q50252211-8F9E83DB-967E-4C22-B06D-235FB2483344Q50879323-757D519A-5198-47E8-871C-A8ACDA0D7EE4Q52605240-09E49B0B-A171-4173-99CB-DC48B7B4B0D1Q55058474-C0F7D148-A72A-4AD2-AE6B-FEB787912D6F
P2860
The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The sodium iodide symporter (N ...... eting for cancer therapeutics.
@ast
The sodium iodide symporter (N ...... eting for cancer therapeutics.
@en
type
label
The sodium iodide symporter (N ...... eting for cancer therapeutics.
@ast
The sodium iodide symporter (N ...... eting for cancer therapeutics.
@en
prefLabel
The sodium iodide symporter (N ...... eting for cancer therapeutics.
@ast
The sodium iodide symporter (N ...... eting for cancer therapeutics.
@en
P2860
P1476
The sodium iodide symporter (N ...... eting for cancer therapeutics.
@en
P2093
Gregory A Brent
Takahiko Kogai
P2860
P304
P356
10.1016/J.PHARMTHERA.2012.06.007
P577
2012-06-29T00:00:00Z